These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19639957)

  • 21. Similarity to molecules in the training set is a good discriminator for prediction accuracy in QSAR.
    Sheridan RP; Feuston BP; Maiorov VN; Kearsley SK
    J Chem Inf Comput Sci; 2004; 44(6):1912-28. PubMed ID: 15554660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward a pharmacophore for kinase frequent hitters.
    Aronov AM; Murcko MA
    J Med Chem; 2004 Nov; 47(23):5616-9. PubMed ID: 15509160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds.
    Srivani P; Sastry GN
    J Mol Graph Model; 2009 Feb; 27(6):676-88. PubMed ID: 19147382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets.
    Gedeck P; Rohde B; Bartels C
    J Chem Inf Model; 2006; 46(5):1924-36. PubMed ID: 16995723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of protein kinases by ATP-STD NMR spectroscopy.
    McCoy MA; Senior MM; Wyss DF
    J Am Chem Soc; 2005 Jun; 127(22):7978-9. PubMed ID: 15926798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.
    Sciabola S; Stanton RV; Wittkopp S; Wildman S; Moshinsky D; Potluri S; Xi H
    J Chem Inf Model; 2008 Sep; 48(9):1851-67. PubMed ID: 18717582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative structure-activity relationship modeling of the toxicity of organothiophosphate pesticides to Daphnia magna and Cyprinus carpio.
    Zvinavashe E; Du T; Griff T; van den Berg HH; Soffers AE; Vervoort J; Murk AJ; Rietjens IM
    Chemosphere; 2009 Jun; 75(11):1531-8. PubMed ID: 19376559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational chemistry approach to protein kinase recognition using 3D stochastic van der Waals spectral moments.
    González-Díaz H; Saíz-Urra L; Molina R; González-Díaz Y; Sánchez-González A
    J Comput Chem; 2007 Apr; 28(6):1042-8. PubMed ID: 17269125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional classification of protein kinase binding sites using Cavbase.
    Kuhn D; Weskamp N; Hüllermeier E; Klebe G
    ChemMedChem; 2007 Oct; 2(10):1432-47. PubMed ID: 17694525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
    Aronov AM; McClain B; Moody CS; Murcko MA
    J Med Chem; 2008 Mar; 51(5):1214-22. PubMed ID: 18288794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.
    Hudelson MG; Ketkar NS; Holder LB; Carlson TJ; Peng CC; Waldher BJ; Jones JP
    J Med Chem; 2008 Feb; 51(3):648-54. PubMed ID: 18211009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can MM-PBSA calculations predict the specificities of protein kinase inhibitors?
    Page CS; Bates PA
    J Comput Chem; 2006 Dec; 27(16):1990-2007. PubMed ID: 17036304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of binding specificity-determining features in protein families.
    Anderson PC; De Sapio V; Turner KB; Elmer SP; Roe DC; Schoeniger JS
    J Med Chem; 2012 Mar; 55(5):1926-39. PubMed ID: 22289061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting binding modes from free energy calculations.
    Nervall M; Hanspers P; Carlsson J; Boukharta L; Aqvist J
    J Med Chem; 2008 May; 51(9):2657-67. PubMed ID: 18410080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global, local and novel consensus quantitative structure-activity relationship studies of 4-(Phenylaminomethylene) isoquinoline-1, 3 (2H, 4H)-diones as potent inhibitors of the cyclin-dependent kinase 4.
    Lei B; Xi L; Li J; Liu H; Yao X
    Anal Chim Acta; 2009 Jun; 644(1-2):17-24. PubMed ID: 19463556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of binding strength in several classes of active site inhibitors of acetylcholinesterase studied by comparative binding energy analysis.
    Martín-Santamaría S; Muñoz-Muriedas J; Luque FJ; Gago F
    J Med Chem; 2004 Aug; 47(18):4471-82. PubMed ID: 15317459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidation of characteristic structural features of ligand binding sites of protein kinases: a neural network approach.
    Niwa T
    J Chem Inf Model; 2006; 46(5):2158-66. PubMed ID: 16995746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-target spectral moment: QSAR for antiviral drugs vs. different viral species.
    Prado-Prado FJ; Borges F; Uriarte E; Peréz-Montoto LG; González-Díaz H
    Anal Chim Acta; 2009 Oct; 651(2):159-64. PubMed ID: 19782806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding site similarity analysis for the functional classification of the protein kinase family.
    Kinnings SL; Jackson RM
    J Chem Inf Model; 2009 Feb; 49(2):318-29. PubMed ID: 19434833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.